Dana Washburn

Dana Washburn

Geen lopende functies
63 jaar
Health Technology
Consumer Services

Profiel

Dana S.
Washburn
worked at Boston Scientific Corp.
as Vice President-Clinical Trials & Safety in 2010.
Served as Chief Medical Officer at Lantheus Medical Imaging, Inc. from 2011 to 2012.
Held the position of Chief Medical & Scientific Officer at Lyra Therapeutics, Inc. from 2019 to 2020.
Worked as Senior Vice President-Clinical Development at Rhythm Pharmaceuticals, Inc. from 2022 to 2026.
Held roles at Alexion Pharmaceuticals, Inc. as Executive Director & Global Medicine Leader and at PAREXEL International Corp.
as Head-Global Medical Services & VP.
Education includes undergraduate studies at Dartmouth College and a doctorate from the University of Massachusetts.

Eerdere bekende functies van Dana Washburn

BedrijvenFunctieEinde
RHYTHM PHARMACEUTICALS, INC. Hoofd Techniek/Wetenschap/O&O 01-02-2026
LYRA THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 01-04-2020
Hoofd Techniek/Wetenschap/O&O 02-11-2012
BOSTON SCIENTIFIC CORPORATION Corporate Officer/Principal 01-01-2010
PAREXEL INTERNATIONAL CORPORATION Corporate Officer/Principal -
Ervaring van Dana Washburn in detail bekijken

Opleiding van Dana Washburn

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

85

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Dana Washburn
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU